Literature DB >> 19664069

Brain angiogenesis in developmental and pathological processes: mechanism and therapeutic intervention in brain tumors.

Woo-Young Kim1, Ho-Young Lee.   

Abstract

Formation of new blood vessels is required for the growth and metastasis of all solid tumors. New blood vessels are established in tumors mainly through angiogenesis. Brain tumors in particular are highly angiogenic. Therefore, interventions designed to prevent angiogenesis may be effective at controlling brain tumors. Indeed, many recent findings from preclinical and clinical studies of antiangiogenic therapy for brain tumors have shown that it is a promising approach to managing this deadly disease, especially when combined with other cytotoxic treatments. In this minireview, we summarize the basic characteristics of brain tumor angiogenesis and the role of known angiogenic factors in regulating this angiogenesis, which may be targets of antiangiogenic therapy. We also discuss the current status of antiangiogenic therapy for brain tumors, the suggested mechanisms of this therapy and the limitations of this strategy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19664069      PMCID: PMC2847309          DOI: 10.1111/j.1742-4658.2009.07177.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  112 in total

Review 1.  Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy.

Authors:  R K Jain
Journal:  Nat Med       Date:  2001-09       Impact factor: 53.440

2.  Akt signaling mediates VEGF/VPF vascular permeability in vivo.

Authors:  Isabelle Six; Yasuko Kureishi; Zhengyu Luo; Kenneth Walsh
Journal:  FEBS Lett       Date:  2002-12-04       Impact factor: 4.124

3.  VEGF effect on vascular permeability is mediated by synthesis of platelet-activating factor.

Authors:  M G Sirois; E R Edelman
Journal:  Am J Physiol       Date:  1997-06

4.  Vessel tortuosity and brain tumor malignancy: a blinded study.

Authors:  Elizabeth Bullitt; Donglin Zeng; Guido Gerig; Stephen Aylward; Sarang Joshi; J Keith Smith; Weili Lin; Matthew G Ewend
Journal:  Acad Radiol       Date:  2005-10       Impact factor: 3.173

5.  Activation of VEGF and Ras genes in gastric mucosa during angiogenic response to ethanol injury.

Authors:  M K Jones; R M Itani; H Wang; M Tomikawa; I J Sarfeh; S Szabo; A S Tarnawski
Journal:  Am J Physiol       Date:  1999-06

Review 6.  Lessons from phase III clinical trials on anti-VEGF therapy for cancer.

Authors:  Rakesh K Jain; Dan G Duda; Jeffrey W Clark; Jay S Loeffler
Journal:  Nat Clin Pract Oncol       Date:  2006-01

7.  Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor.

Authors:  W L Monsky; D Fukumura; T Gohongi; M Ancukiewcz; H A Weich; V P Torchilin; F Yuan; R K Jain
Journal:  Cancer Res       Date:  1999-08-15       Impact factor: 12.701

8.  VEGF-Trap: a VEGF blocker with potent antitumor effects.

Authors:  Jocelyn Holash; Sam Davis; Nick Papadopoulos; Susan D Croll; Lillian Ho; Michelle Russell; Patricia Boland; Ray Leidich; Donna Hylton; Elena Burova; Ella Ioffe; Tammy Huang; Czeslaw Radziejewski; Kevin Bailey; James P Fandl; Tom Daly; Stanley J Wiegand; George D Yancopoulos; John S Rudge
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

9.  VEGF induces hyperpermeability by a direct action on endothelial cells.

Authors:  S Hippenstiel; M Krüll; A Ikemann; W Risau; M Clauss; N Suttorp
Journal:  Am J Physiol       Date:  1998-05

10.  Tumor induction of VEGF promoter activity in stromal cells.

Authors:  D Fukumura; R Xavier; T Sugiura; Y Chen; E C Park; N Lu; M Selig; G Nielsen; T Taksir; R K Jain; B Seed
Journal:  Cell       Date:  1998-09-18       Impact factor: 41.582

View more
  19 in total

1.  Angiopoietin-4 promotes glioblastoma progression by enhancing tumor cell viability and angiogenesis.

Authors:  Melissa K Brunckhorst; Hui Wang; Rong Lu; Qin Yu
Journal:  Cancer Res       Date:  2010-09-07       Impact factor: 12.701

2.  Insulin-like growth factor binding protein-3 suppresses vascular endothelial growth factor expression and tumor angiogenesis in head and neck squamous cell carcinoma.

Authors:  Seung-Hyun Oh; Woo-Young Kim; Ok-Hee Lee; Ju-Hee Kang; Jong-Kyu Woo; Jai-Hyun Kim; Bonnie Glisson; Ho-Young Lee
Journal:  Cancer Sci       Date:  2012-05-25       Impact factor: 6.716

3.  Nano to micro delivery systems: targeting angiogenesis in brain tumors.

Authors:  Ariel Gilert; Marcelle Machluf
Journal:  J Angiogenes Res       Date:  2010-10-08

4.  Vascular gene expression patterns are conserved in primary and metastatic brain tumors.

Authors:  Yang Liu; Eleanor B Carson-Walter; Anna Cooper; Bethany N Winans; Mahlon D Johnson; Kevin A Walter
Journal:  J Neurooncol       Date:  2010-01-09       Impact factor: 4.130

5.  Role of collagen matrix in tumor angiogenesis and glioblastoma multiforme progression.

Authors:  Tadanori Mammoto; Amanda Jiang; Elisabeth Jiang; Dipak Panigrahy; Mark W Kieran; Akiko Mammoto
Journal:  Am J Pathol       Date:  2013-08-05       Impact factor: 4.307

6.  A very rare cancer in Down syndrome: medulloblastoma. Epidemiological data from 13 countries.

Authors:  Daniel Satgé; Charles A Stiller; Stefan Rutkowski; André O von Bueren; Brigitte Lacour; Danièle Sommelet; Motoi Nishi; Maura Massimino; Maria Luisa Garré; Florencia Moreno; Henrik Hasle; Zsuzsanna Jakab; Mark Greenberg; Nicolas von der Weid; Claudia Kuehni; Oscar Zurriaga; Maria-Luisa Vicente; Rafael Peris-Bonet; Martin Benesch; Michel Vekemans; Sheena G Sullivan; Christian Rickert
Journal:  J Neurooncol       Date:  2013-01-11       Impact factor: 4.130

Review 7.  Monoclonal antibodies in neuro-oncology: Getting past the blood-brain barrier.

Authors:  Lois A Lampson
Journal:  MAbs       Date:  2011-03-01       Impact factor: 5.857

Review 8.  The immunological effect of hyaluronan in tumor angiogenesis.

Authors:  Fiorella M Spinelli; Daiana L Vitale; Gianina Demarchi; Carolina Cristina; Laura Alaniz
Journal:  Clin Transl Immunology       Date:  2015-12-04

9.  Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases.

Authors:  Natsuko Nomura; Sandra Pastorino; Pengfei Jiang; Gage Lambert; John R Crawford; Marco Gymnopoulos; David Piccioni; Tiffany Juarez; Sandeep C Pingle; Milan Makale; Santosh Kesari
Journal:  Cancer Cell Int       Date:  2014-03-20       Impact factor: 5.722

10.  Molecular Targets and Treatment of Meningioma.

Authors:  Rickey Miller; Michele L DeCandio; Yaenette Dixon-Mah; Pierre Giglio; W Alex Vandergrift; Naren L Banik; Sunil J Patel; Abhay K Varma; Arabinda Das
Journal:  J Neurol Neurosurg       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.